Rritual Superfoods to raise up to $6M in CSE IPO
2021-03-02
Rritual filed final prospectus in connection with its IPO on CSE and will 17,391,305 units at $0.30 per unit for gross proceeds of $5,217,391.50.Read More →
Triumvira Immunologics secures US $55M Series A led by Bayer and Northpond Ventures
2020-08-27
Triumvira Immunologics secured US $55M Series A funding from Leaps by Bayer, Northpond Ventures, Oceanpine Capital, Viva Biotech Holdings, Bloom Burton & Co., the Centre for Commercialization of Cancer Immunotherapy (C3i).Read More →
CPP Investments and PSP investments invest in Sana’s US $700M initial financing
2020-06-23
Canada Pension Plan Investment Board, Public Sector Pension Investment Board are among a group of investors backing Sana Biotechnology.Read More →
Biofourmis acquires Biovotion AG
2019-11-18
Biofourmis to acquire Zürich, Switzerland based Biovotion AG, a leading developer of a cutting-edge clinical-grade wearable biosensor platform.Read More →
Leo Resources Inc. completes acquisition of Green Life Clinics
2018-08-27
Leo Resources Inc. Completes Acquisition of Green Life Clinics, Set to Begin Trading as Global Health Clinics Under Symbol “MJRX”Read More →
Canopy Growth completed the acquistion of Canppy Health Innovations
2018-08-07
CANOPY GROWTH STRENGTHENS COMMITMENT TO CANNABIS-BASED MEDICINES THROUGH COMPLETION OF CANOPY HEALTH INNOVATIONS ACQUISITIONRead More →
Akumi to acquire US $27.5M revenue business in florida
2018-08-01
Akumin Inc. (TSX: AKU.U) t to acquire a freestanding, fixed-site outpatient diagnostic imaging business located in Florida for US $27.5 million.Read More →
Akumin completes US $35M bought deal financing
2018-05-02
Akumin Inc. (TSX: AKU.U) completed bought deal offering of 8,750,000 common shares at US $4.00 for gross proceeds of US $35,000,000. Clarus Securities Inc. led the offering.Read More →
Akumin announces US $35M bought deal
2018-04-11
Akumin (TSX: AKU.U) engaged Clarus Securities Inc. for a bought deal of 8,750,000 Common Shares at US $4.00 for gross proceeds of US $35,000,000 Read More →
DiaMedica Therapeutics closes US $2.5M final tranche of private placemet
2018-03-29
DiaMedica Therapeutics (TSX-V: DMA; OTCQB: DMCAF) closed second and final tranche of offering for gross proceeds of approximately US$2.5M. The company raised US $6.3M in two tranches.Read More →
Xenon Pharmaceuticals closes Teva and BVF transactions
2018-03-28
Xenon Pharmaceuticals (NASDAQ: XENE) terminated collaborative development and license agreement with Teva Pharmaceuticals and closed share exchange transaction with Biotechnology Value Fund (BVF)Read More →
Profound Medical completes $34.5M bought deal
2018-03-20
Profound Medical Corp. (TSX-V: PRN; OTCQX: PRFMF) closed previously announced bought for gross proceeds of $34.5M. Canaccord Genuity Corp. led the offeringRead More →
